Merck & Co., Inc. (TSX:MRK)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CAD 403.53 billion. The enterprise value is 452.81 billion.

Market Cap	403.53B
Enterprise Value	452.81B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Dec 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.22%
Float	2.47B

Valuation Ratios

The trailing PE ratio is 16.12 and the forward PE ratio is 23.14.

PE Ratio	16.12
Forward PE	23.14
PS Ratio	4.53
PB Ratio	5.59
P/TBV Ratio	67.72
P/FCF Ratio	23.81
P/OCF Ratio	17.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.21, with an EV/FCF ratio of 26.72.

EV / Earnings	18.09
EV / Sales	5.09
EV / EBITDA	11.21
EV / EBIT	13.53
EV / FCF	26.72

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio	1.54
Quick Ratio	0.96
Debt / Equity	0.96
Debt / EBITDA	1.71
Debt / FCF	4.09
Interest Coverage	18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 28.30%.

Return on Equity (ROE)	36.88%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	28.30%
Return on Capital Employed (ROCE)	22.54%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.20M
Profits Per Employee	338,222
Employee Count	74,000
Asset Turnover	0.51
Inventory Turnover	2.32

Taxes

In the past 12 months, Merck & Co. has paid 3.84 billion in taxes.

Income Tax	3.84B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +31.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.77%
50-Day Moving Average	24.96
200-Day Moving Average	20.64
Relative Strength Index (RSI)	69.34
Average Volume (20 Days)	5,010

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.11

Income Statement

In the last 12 months, Merck & Co. had revenue of CAD 89.14 billion and earned 25.03 billion in profits. Earnings per share was 9.98.

Revenue	89.14B
Gross Profit	68.82B
Operating Income	33.55B
Pretax Income	28.89B
Net Income	25.03B
EBITDA	39.91B
EBIT	33.55B
Earnings Per Share (EPS)	9.98

Balance Sheet

The company has 19.97 billion in cash and 69.29 billion in debt, with a net cash position of -49.32 billion.

Cash & Cash Equivalents	19.97B
Total Debt	69.29B
Net Cash	-49.32B
Net Cash Per Share	n/a
Equity (Book Value)	72.21B
Book Value Per Share	29.15
Working Capital	20.83B

Cash Flow

In the last 12 months, operating cash flow was 22.59 billion and capital expenditures -5.64 billion, giving a free cash flow of 16.95 billion.

Operating Cash Flow	22.59B
Capital Expenditures	-5.64B
Free Cash Flow	16.95B
FCF Per Share	n/a

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin	77.21%
Operating Margin	37.64%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.77%
EBIT Margin	37.64%
FCF Margin	19.01%

Dividends & Yields

This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 2.68%.

Dividend Per Share	0.74
Dividend Yield	2.68%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	44.79%
Buyback Yield	1.34%
Shareholder Yield	4.02%
Earnings Yield	6.20%
FCF Yield	4.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score	3.5
Piotroski F-Score	5